CIK 0001434647 · Non-accelerated filer<br>Smaller reporting company
ZEVRA THERAPEUTICS, INC.
Sign in to watch- Ticker
- ZVRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 205894398
- Phone
- (888) 958-1253
- Business address
- 101 FEDERAL STREET, BOSTON, MA, 02110
- Former names
- KEMPHARM, INC, KEMPHARM INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $224,948
- in 1 filing, $225K under 10b5-1 plans
Net −$224,948. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-30 | Thompson Rahsaan Chief Legal & Compliance | Grant or award · Restricted Stock Unit | +34,000 | 34,000 | ||
| 2025-01-30 | Schafer Joshua CCO & EVP, Bus. Development | Grant or award · Stock Option (right to buy) | +68,000 | 68,000 | ||
| 2025-01-30 | Schafer Joshua CCO & EVP, Bus. Development | Grant or award · Restricted Stock Unit | +34,000 | 34,000 | ||
| 2025-01-30 | Clifton R. LaDuane CFO & Treasurer | Grant or award · Stock Option (right to buy) | +68,000 | 68,000 | ||
| 2025-01-30 | Clifton R. LaDuane CFO & Treasurer | Grant or award · Restricted Stock Unit | +34,000 | 34,000 | ||
| 2024-10-11 | Watton Corey Michael Director | Purchase | +500 | $7.92 | $4K | 1,500 |
| 2024-07-17 | Clifton R. LaDuane CFO & Treasurer | Purchase | +2,000 | $6.77 | $14K | 18,469 |
| 2024-07-16 | Anderson Thomas Director | Purchase | +10,000 | $6.81 | $68K | 20,000 |
| 2024-07-12 | Bode John B Director | Purchase | +10,000 | $5.87 | $59K | 30,000 |
| 2024-06-21 | Thompson Rahsaan Chief Legal & Compliance | Grant or award · Restricted Stock Unit | +200,000 | 200,000 | ||
| 2024-05-13 | Bode John B Director | Grant or award · Stock Option (right to buy) | +39,200 | 39,200 | ||
| 2024-05-13 | DIXON WENDY L Director | Grant or award · Stock Option (right to buy) | +39,200 | 39,200 | ||
| 2024-05-13 | FAVORITO TAMARA A Director | Grant or award · Stock Option (right to buy) | +49,200 | 49,200 | ||
| 2024-05-13 | Calder Douglas W Director | Grant or award · Stock Option (right to buy) | +39,200 | 39,200 | ||
| 2024-05-13 | Watton Corey Michael Director | Grant or award · Stock Option (right to buy) | +39,200 | 39,200 | ||
| 2024-05-13 | Shih Alvin Director | Grant or award · Stock Option (right to buy) | +39,200 | 39,200 | ||
| 2024-05-13 | Anderson Thomas Director | Grant or award · Stock Option (right to buy) | +39,200 | 39,200 | ||
| 2024-01-31 | Schafer Joshua CCO & EVP, Bus. Development | Grant or award · Restricted Stock Unit | +106,000 | 106,000 | ||
| 2024-01-31 | Sangiovanni Timothy J. SVP, Corporate Controller | Grant or award · Restricted Stock Unit | +35,000 | 35,000 | ||
| 2024-01-31 | Mickle Christal M M Chief Development Officer | Grant or award · Restricted Stock Unit | +77,000 | 77,000 |
Page 6 of 9 · 166 trades